Search Results
Our Leadership
Our forward-looking leadership team is made up of dedicated, focused and experienced executives. Working with each other and with our employees worldwide, their knowledge and experience come together to make a difference for all our stakeholders – patients, healthcare providers, employees, investors and communities around the globe.
Partners and Suppliers
Partnering with Baxter to provide life-saving and -sustaining products and therapies globally.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2024, to stockholders of record as of May 31, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter
Baxter to Present at Bank of America 2024 Health Care Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America 2024 Health Care Conference on Wednesday, May 15, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 3:00 p.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Wednesday, August 14, 2024. About Baxter
Baxter Reports First-Quarter 2024 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
Baxter to Host First-Quarter 2024 Conference Call for Investors Financial Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time.